Profits at one of the UK’s best‑known pet retailers have taken such a hard hit that its leader is calling for “urgent and necessary” change to keep the business on track. And this is the part most people miss: the company is still making strong money in one area, yet its core retail arm is struggling badly—raising big questions about strategy, leadership, and what pet owners really want from the brand.
Leadership in crisis mode
Pets at Home has been thrown into a leadership gap after the sudden exit of former chief executive Lyssa McGowan in September, leaving the group still hunting for a permanent CEO to steer the turnaround. In the meantime, interim executive chair Ian Burke has stepped into the spotlight, arguing that the 34‑year‑old chain must “return to our retailing roots” if it wants to revive performance and reconnect with customers who once saw it as the go‑to pet destination.
Burke, who took on interim CEO responsibilities around 10 weeks ago, says his focus is twofold: fix the problems dragging down the retail side while protecting the strong momentum in the veterinary division. That balancing act is crucial because any misstep could either delay a retail recovery or risk weakening the part of the business that’s currently propping up group profits.
Profit slump and mixed results
In its latest half‑year update, Pets at Home reported that underlying profit before tax fell by 33.5%, dropping to £36.2 million over the 28 weeks to 9 October. That steep decline stems largely from the retail arm, where profits collapsed by 84% to just £3.5 million, alongside a 2.3% fall in revenue to £679.9 million—numbers that would alarm any shareholder watching the company’s traditional store business.
Yet there is a striking contrast: the group’s veterinary services are performing strongly, with revenues rising 6.7% to £376 million and profits increasing 8.3% to £45 million. This split performance—weak retail, strong vets—raises a controversial question: is Pets at Home slowly becoming more of a healthcare and services company than a traditional pet retailer, and should its future strategy lean more heavily into that shift?
Share price reaction and investor expectations
Despite the profit slump, the company’s shares, which had been stuck around their lowest levels since March 2020, actually jumped nearly 5% on the morning of the results. That rise suggests investors had braced for even worse numbers and were relieved by signs that management has a clear plan, however painful, to stabilise the business.
Looking ahead, Pets at Home expects to deliver full‑year underlying profit before tax in the range of £90 million to £100 million. Strikingly, more than £80 million of that is forecast to come from its vet group, meaning the majority of expected profit is now tied to services rather than selling pet food, toys, and accessories. But here’s where it gets controversial: if the vets are driving most of the profit, should investors still view this primarily as a retail stock, or as something closer to a healthcare‑services play?
What went wrong in retail
The company says it has pinpointed two main issues dragging down its retail performance and has launched a £20 million cost‑cutting programme to address them. First, it has been hit hard in advanced nutrition, as pet owners increasingly switch to new premium pet food brands that sell directly to consumers—often online—bypassing traditional retailers and eroding demand for established brands.
Pets at Home admits it is “overexposed” to these traditional nutrition brands, meaning it relies too heavily on products that customers are now abandoning in favour of fresher, often subscription‑based alternatives. This shift highlights a broader industry trend: younger, digitally savvy pet owners are happy to pay for niche, high‑quality food delivered to their door, rather than buying mass‑market brands from store shelves.
Accessories and self‑inflicted damage
The second problem area is accessories, such as toys, beds, leads, and other non‑food items, where the company has seen declines over the past three years. In its most recent figures, accessories sales fell 5.9% year on year, adding further pressure to the retail division at a time when every category matters.
What makes this even more striking is that Pets at Home admits a big chunk of the damage is “self‑inflicted.” Management concedes that the business has not consistently offered the right products at the right prices, nor executed ranges and merchandising as well as it should. In simple terms, customers haven’t always been able to find what they want, at a price that feels fair, presented in a way that encourages them to buy—and that’s a tough pill to swallow for a retailer with decades of experience.
CEO exit and ongoing uncertainty
Former CEO Lyssa McGowan resigned in September after the company issued two profit warnings in the space of just two months, a clear sign that the board and investors had lost patience with the pace or direction of the turnaround. Her departure not only triggered the current leadership vacuum but also raised concerns about how quickly a new permanent CEO can be found and whether that person will double down on the current strategy or rip up the playbook.
This leadership uncertainty adds another layer of risk at a time when the company is already juggling falling retail profits, changing consumer habits, and a rapidly evolving competitive landscape. And this is the part most people miss: even if the financial numbers improve, a prolonged period without a strong, permanent leader could slow decision‑making just when bold, decisive moves are most needed.
Regulatory pressure on vet prices
On top of internal challenges, Pets at Home’s lucrative vet business faces external pressure from regulators. In October, the UK competition watchdog proposed 21 measures aimed at the veterinary market, including potential price caps on prescription costs and new requirements for greater price transparency.
The regulator highlighted that prices for veterinary services across the market have jumped by 63% between 2016 and 2023, intensifying scrutiny on how much pet owners are being charged. A controversial question now hangs over the sector: if regulators push through strict measures to protect consumers, will that significantly cut into the profit growth that companies like Pets at Home have been enjoying from vet services?
Big picture: turnaround or transformation?
Taken together, Pets at Home is facing a complex crossroads: a struggling retail arm in need of urgent repair, a booming vet division under increasing regulatory scrutiny, and a leadership team still in transition. The £20 million cost‑cutting plan and renewed focus on “retailing roots” signal a desire to fix the basics, but the deeper challenge is adapting to a world where pet owners are more digital, more demanding, and more value‑conscious than ever before.
Some might argue that the company should lean harder into services and healthcare, letting the traditional retail offering play a supporting role rather than trying to restore it to its former glory. Others will insist that a strong, well‑run retail chain remains the heart of the brand’s identity and customer experience. So what do you think: should Pets at Home double down on its vet and services business, or fight to reinvent its retail stores for a new generation of pet owners—and where do you believe the real long‑term value lies?
